levodopa has been researched along with sphingosine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Soares-da-Silva, P | 2 |
| Claessens, T; Degroote, S; Hirabayashi, Y; Klumperman, J; Oorschot, V; Sprong, H; van der Sluijs, P; van Drunen, J; van Meer, G; Westerink, BH | 1 |
| Gupta, BS; Tiwary, AK | 1 |
| Bembi, B; LaMarca, ME; Orvisky, E; Rosenbaum, H; Schiffmann, R; Sidransky, E; Stubblefield, B; Tayebi, N; Walker, J; Wong, K | 1 |
| Babita, K; Tiwary, AK | 1 |
7 other study(ies) available for levodopa and sphingosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Renal tubular dopamine outward transfer during Na(+)-H+ exchange activation by alpha 1- and alpha 2-adrenoceptor agonists.
Topics: Adrenergic alpha-Agonists; Amiloride; Animals; Bucladesine; Colforsin; Dopamine; Hydrogen; In Vitro Techniques; Kidney Tubules; Levodopa; Phenylephrine; Phorbol 12,13-Dibutyrate; Quinoxalines; Rats; Sodium; Sphingosine | 1993 |
Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Calcimycin; Dopamine; Enzyme Activation; Kidney; Kinetics; Levodopa; Male; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Wistar; Sodium, Dietary; Sphingosine | 1993 |
Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex.
Topics: Animals; Binding Sites; Cattle; Cell Membrane; CHO Cells; Cricetinae; Enzyme Activation; Glucosyltransferases; Glycosphingolipids; Golgi Apparatus; Levodopa; Lysosomes; Melanins; Melanosomes; Membrane Glycoproteins; Mice; Monophenol Monooxygenase; Neoplasm Proteins; Oxidoreductases; Pigmentation; Protein Transport; Proteins; Psychosine; Sphingosine; Tumor Cells, Cultured; Vacuoles | 2001 |
Role of sphingosine synthesis inhibition in transcutaneous delivery of levodopa.
Topics: Acyltransferases; Administration, Cutaneous; Animals; beta-Alanine; Carbidopa; Dopamine Agents; Drug Stability; Enzyme Inhibitors; Female; Levodopa; Male; Rats; Rats, Wistar; Serine C-Palmitoyltransferase; Skin; Skin Absorption; Solvents; Sphingosine | 2002 |
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
Topics: Adult; Blotting, Southern; Brain; Deoxyribonucleases, Type II Site-Specific; Female; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Homozygote; Humans; Levodopa; Male; Middle Aged; Mutation; Parkinson Disease; Psychosine; Sphingosine | 2003 |
Skin lipid synthesis inhibition: a possible means for enhancing percutaneous delivery of levodopa.
Topics: Administration, Cutaneous; Animals; Anticholesteremic Agents; Antiparkinson Agents; Atorvastatin; beta-Alanine; Calcium Channel Blockers; Calcium Chloride; Cholesterol; Dose-Response Relationship, Drug; Ethanol; Female; Heptanoic Acids; In Vitro Techniques; Levodopa; Male; Pyrroles; Rats; Rats, Wistar; Serine C-Palmitoyltransferase; Skin; Sphingosine; Time Factors; Verapamil | 2004 |